Sakado, Japan

Katsuyoshi Sunaga

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nitta Gelatin Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuyoshi Sunaga: Innovator in Brain Function Regulation

Introduction

Katsuyoshi Sunaga is a notable inventor based in Sakado, Japan. He has made significant contributions to the field of brain function regulation through his innovative research and development. His work focuses on creating products that enhance cognitive functions, which can have a profound impact on health and wellness.

Latest Patents

Katsuyoshi Sunaga holds a patent for a brain function regulating agent, which includes a peptide with the amino acid sequence represented by Glu-Hyp-Gly. This agent can be utilized in food or beverage products, providing a unique approach to improving brain function. The patent highlights the potential of using peptides as functional ingredients in everyday consumables.

Career Highlights

Sunaga is associated with Nitta Gelatin Inc., a company known for its advancements in gelatin and related products. His role at the company allows him to explore innovative solutions that bridge the gap between food science and cognitive health. His dedication to research has positioned him as a key player in the field of functional foods.

Collaborations

Katsuyoshi Sunaga collaborates with talented individuals such as Naoki Inoue and Hidetomo Kikuchi. These partnerships enhance the research and development process, fostering an environment of creativity and innovation.

Conclusion

Katsuyoshi Sunaga's work in brain function regulation exemplifies the intersection of science and health. His contributions through patents and collaborations continue to pave the way for advancements in cognitive enhancement products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…